Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of <i>Helicobacter pylori</i>

<div>Flow diagram of this study. RMAB group: rabeprazole plus minocycline, amoxicillin, and bismuth; RMMB group: rabeprazole plus minocycline, metronidazole, and bismuth; RACB group: rabeprazole plus amoxicillin, clarithromycin, and bismuth. ITT: intention-to-treat; PP: per protocol.</div>

Gastroenterology Research and Practice

fig1

Figure 1

Figure 1: Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of <i>Helicobacter pylori</i> 

Gastroenterology Research and Practice

Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori

Figure 1